{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:17:01Z","timestamp":1793650621652,"version":"4.5.1"},"reference-count":195,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,6,12]]},"DOI":"10.3233\/jad-179925","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T11:37:35Z","timestamp":1525001855000},"page":"S313-S327","source":"Crossref","is-referenced-by-count":40,"title":["Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"64","author":[{"given":"M. Clara","family":"Selles","sequence":"first","affiliation":[{"name":"Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio M.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio T.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil"},{"name":"Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-179925_ref1","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2015) World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. Working Paper No. ESA\/P\/WP.241."},{"key":"10.3233\/JAD-179925_ref3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer\u2019s disease facts and figures","volume":"13","author":"Alzheimer\u2019s Association","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179925_ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.65.6_suppl_3.S10","article-title":"The staging and assessment of moderate to severe Alzheimer disease","volume":"65","author":"Feldman","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-179925_ref6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1192\/bjp.181.6.463","article-title":"Managing behavioural and psychological symptoms in dementia","volume":"181","author":"Lawlor","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-179925_ref7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179925_ref8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/jnp.17.3.342","article-title":"Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer\u2019s disease","volume":"17","author":"Landes","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-179925_ref9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/gps.490","article-title":"The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer\u2019s disease patients","volume":"17","author":"Beeri","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00019442-200205000-00013","article-title":"Comparison of healthcare utilization and direct costs in three degenerative dementias","volume":"10","author":"Murman","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin Anat"},{"key":"10.3233\/JAD-179925_ref12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-179925_ref13","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1523\/JNEUROSCI.23-17-06740.2003","article-title":"\u03b2-Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex","volume":"23","author":"Dougherty","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-179925_ref15","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179925_ref17","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/lm.1310209","article-title":"Amyloid beta mediates memory formation","volume":"16","author":"Garcia-Osta","year":"2009","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-179925_ref19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-130740","article-title":"Picomolar amyloid-beta peptides enhance spontaneous astrocyte calcium transients","volume":"38","author":"Lee","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179925_ref20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.24130","article-title":"A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid beta","volume":"75","author":"Ricciarelli","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179925_ref21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3233\/JAD-179925_ref22","first-page":"1293","article-title":"Diffuse plaques do not accentuate synapse loss in Alzheimer\u2019s disease","volume":"137","author":"Masliah","year":"1990","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179925_ref23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179925_ref24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer\u2019s disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179925_ref25","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1523\/JNEUROSCI.22-15-06331.2002","article-title":"Reversible memory loss in a mouse transgenic model of Alzheimer\u2019s disease","volume":"22","author":"Kotilinek","year":"2002","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-179925_ref27","doi-asserted-by":"crossref","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-179925_ref28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-179925_ref29","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer\u2019s disease affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref30","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer\u2019s-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref32","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-179925_ref34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(01)03058-X","article-title":"Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus","volume":"924","author":"Wang","year":"2002","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179925_ref35","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1074\/jbc.M110.177790","article-title":"Activation of D1\/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers","volume":"286","author":"Jurgensen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref36","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-179925_ref37","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","article-title":"Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers","volume":"33","author":"Figueiredo","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-a mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-179925_ref39","doi-asserted-by":"crossref","first-page":"13629","DOI":"10.1523\/JNEUROSCI.1353-14.2014","article-title":"Alzheimer\u2019s disease-like pathology induced by amyloid-\u03b2 oligomers in nonhuman primates","volume":"34","author":"Forny-Germano","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref40","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1074\/jbc.M116.761189","article-title":"Interaction of amyloid-beta (Abeta) oligomers with neurexin 2alpha and neuroligin 1 mediates synapse damage and memory loss in mice","volume":"292","author":"Brito-Moreira","year":"2017","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer\u2019s disease: An emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179925_ref42","doi-asserted-by":"crossref","first-page":"24414","DOI":"10.1074\/jbc.M602363200","article-title":"Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: Stable trimer or tetramer formation by Abeta42","volume":"281","author":"Chen","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref43","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref44","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","article-title":"Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: Prevention by systemic passive immunization","volume":"28","author":"Klyubin","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref45","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179925_ref47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J Physiol"},{"key":"10.3233\/JAD-179925_ref48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","article-title":"The role of cell-derived oligomers of Abeta in Alzheimer\u2019s disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-179925_ref49","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/cn300122k","article-title":"Synapse-binding subpopulations of Abeta oligomers sensitive to peptide assembly blockers and scFv antibodies","volume":"3","author":"Velasco","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-179925_ref50","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref51","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer\u2019s toxic amyloid-beta peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179925_ref52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179925_ref53","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.M109.057182","article-title":"Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption","volume":"285","author":"Zhao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-179925_ref55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-179925_ref56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179925_ref57","doi-asserted-by":"crossref","first-page":"21945","DOI":"10.1074\/jbc.M116.738286","article-title":"Regulation of amyloid beta oligomer binding to neurons and neurotoxicity by the prion protein-mGluR5 complex","volume":"291","author":"Beraldo","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2015.08.107","article-title":"The soluble extracellular fragment of neuroligin-1 targets Abeta oligomers to the postsynaptic region of excitatory synapses","volume":"466","author":"Dinamarca","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-179925_ref59","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.3233\/JAD-179925_ref60","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1074\/jbc.M115.643577","article-title":"Prion-protein-interacting amyloid-beta oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models","volume":"290","author":"Kostylev","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nn.3486","article-title":"Suppression of eIF2alpha kinases alleviates Alzheimer\u2019s disease-related plasticity and memory deficits","volume":"16","author":"Ma","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179925_ref62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.arr.2004.05.002","article-title":"Reactive oxygen species and synaptic plasticity in the aging hippocampus","volume":"3","author":"Serrano","year":"2004","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-179925_ref63","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref64","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1523\/JNEUROSCI.3351-16.2017","article-title":"Astrocyte transforming growth factor beta 1 protects synapses against Abeta oligomers in Alzheimer\u2019s disease model","volume":"37","author":"Diniz","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-179925_ref66","doi-asserted-by":"crossref","first-page":"17112","DOI":"10.1074\/jbc.M116.720664","article-title":"Oligomers of amyloid beta prevent physiological activation of the cellular prion protein-metabotropic glutamate receptor 5 complex by glutamate in Alzheimer disease","volume":"291","author":"Haas","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179925_ref67","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.0722-17.2017","article-title":"Conditional deletion of Prnp rescues behavioral and synaptic deficits after disease onset in transgenic Alzheimer\u2019s disease","volume":"37","author":"Salazar","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-179925_ref69","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","article-title":"Auguste D and Alzheimer\u2019s disease","volume":"349","author":"Maurer","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-179925_ref70","first-page":"497","article-title":"Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment","volume":"3","author":"Finkel","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-179925_ref71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0277-9536(99)00471-2","article-title":"Self-identity in older persons suffering from dementia: Preliminary results","volume":"51","author":"Cohen-Mansfield","year":"2000","journal-title":"Soc Sci Med"},{"key":"10.3233\/JAD-179925_ref72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/eb-2015-102059","article-title":"Non-pharmacological interventions for agitation in dementia: Various strategies demonstrate effectiveness for care home residents; further research in home settings is needed","volume":"19","author":"Cohen-Mansfield","year":"2016","journal-title":"Evid Based Nurs"},{"key":"10.3233\/JAD-179925_ref73","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/13607863.2011.569480","article-title":"Reducing verbal agitation in people with dementia: Evaluation of an intervention based on the satisfaction of basic needs","volume":"15","author":"Bedard","year":"2011","journal-title":"Aging Ment Health"},{"key":"10.3233\/JAD-179925_ref74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3928\/19404921-20101001-98","article-title":"Pilot study of a nonpharmacological intervention for delirium superimposed on dementia","volume":"4","author":"Kolanowski","year":"2011","journal-title":"Res Gerontol Nurs"},{"key":"10.3233\/JAD-179925_ref75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4088\/JCP.12m07918","article-title":"Efficacy of nonpharmacologic interventions for agitation in advanced dementia: A randomized, placebo-controlled trial","volume":"73","author":"Cohen-Mansfield","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JAD-179925_ref76","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2012.12.001","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease: Past progress and anticipation of the future","volume":"9","author":"Geda","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179925_ref77","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaneurol.2013.603","article-title":"Late-life depression, mild cognitive impairment, and dementia","volume":"70","author":"Richard","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-179925_ref78","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer\u2019s dementia and death: The Cache County Dementia Progression Study","volume":"172","author":"Peters","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-179925_ref79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jagp.2014.11.002","article-title":"Beyond memory: A focus on the other neuropsychiatric symptoms of dementia","volume":"23","author":"Peters","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: Possible continuum?","volume":"18","author":"Panza","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: The MIRAGE Study","volume":"60","author":"Green","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-179925_ref82","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-179925_ref83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/156720510790691173","article-title":"Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease","volume":"7","author":"Borroni","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-179925_ref84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2012.07.015","article-title":"Dopamine D(2)-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer\u2019s disease patients","volume":"64","author":"Martorana","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-179925_ref85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnagi.2015.00067","article-title":"Catecholamine-based treatment in AD patients: Expectations and delusions","volume":"7","author":"Stefani","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-179925_ref86","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jalz.2012.10.005","article-title":"Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer\u2019s disease","volume":"9","author":"Trzepacz","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179925_ref87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2013.05.021","article-title":"Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer\u2019s disease","volume":"548","author":"Son","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-179925_ref88","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000335778","article-title":"Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer\u2019s disease","volume":"32","author":"Palmqvist","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-179925_ref89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopsych.2004.11.035","article-title":"Regional cerebral metabolism in early Alzheimer\u2019s disease with clinically significant apathy or depression","volume":"57","author":"Holthoff","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179925_ref90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jad.2011.11.002","article-title":"The influence of subcortical ischemic lesions on cognitive function and quality of life in late life depression","volume":"136","author":"Kang","year":"2012","journal-title":"J Affect Disord"},{"key":"10.3233\/JAD-179925_ref91","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1819.2010.02083.x","article-title":"Frontal hypoperfusion in depressed patients with dementia of Alzheimer type demonstrated on 3DSRT","volume":"64","author":"Kataoka","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-179925_ref92","first-page":"218","article-title":"Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease","volume":"33","author":"Levy-Cooperman","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"10.3233\/JAD-179925_ref93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pscychresns.2014.10.008","article-title":"Left frontal lobe hypoperfusion and depressive symptoms in Alzheimer\u2019s disease patients taking cholinesterase inhibitors","volume":"224","author":"Oshima","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-179925_ref94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pscychresns.2013.11.002","article-title":"Depressive symptoms and regional cerebral blood flow in Alzheimer\u2019s disease","volume":"221","author":"Terada","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-179925_ref95","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.3233\/JAD-179925_ref96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-2012-120169","article-title":"Neuropsychiatric symptoms in older people with and without cognitive impairment","volume":"31","author":"Brodaty","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179925_ref97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/gps.1044","article-title":"Do caregiver management strategies influence patient behaviour in dementia?","volume":"19","author":"de Vugt","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8510(03)00083-6","article-title":"The impact of ageing on hospital care and long-term care\u2013the example of Germany","volume":"67","author":"Schulz","year":"2004","journal-title":"Health Policy"},{"key":"10.3233\/JAD-179925_ref99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer\u2019s disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-179925_ref100","doi-asserted-by":"crossref","first-page":"e45179","DOI":"10.1371\/journal.pone.0045179","article-title":"Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer\u2019s disease mouse model","volume":"7","author":"Adebakin","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179925_ref101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-179925_ref102","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Crosstalk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-\u03b2 oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref103","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-179925_ref104","first-page":"pyu020","article-title":"Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer\u2019s disease","volume":"31","author":"Romano","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.3233\/JAD-179925_ref105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/biof.1369","article-title":"Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer\u2019s disease","volume":"43","author":"Nie","year":"2017","journal-title":"Biofactors"},{"key":"10.3233\/JAD-179925_ref106","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1532-5415.1998.tb04537.x","article-title":"The association of weight change in Alzheimer\u2019s disease with severity of disease and mortality: A longitudinal analysis","volume":"46","author":"White","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-179925_ref107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.1996.tb00912.x","article-title":"Weight change in Alzheimer\u2019s disease","volume":"44","author":"White","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-179925_ref108","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S1041610292000930","article-title":"Nutritional patterns and weight change in Alzheimer patients","volume":"4","author":"Wolf-Klein","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-179925_ref109","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-161205","article-title":"Modeling the relationships among late-life body mass index, cerebrovascular disease, and Alzheimer\u2019s disease neuropathology in an autopsy sample of 1,421 subjects from the National Alzheimer\u2019s Coordinating Center Data Set","volume":"57","author":"Alosco","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179925_ref110","first-page":"243","article-title":"Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer\u2019s disease","volume":"134","author":"Ogomori","year":"1989","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179925_ref111","first-page":"681","article-title":"Molecular features of hypothalamic plaques in Alzheimer\u2019s disease","volume":"139","author":"Standaert","year":"1991","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179925_ref112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-2010-1364","article-title":"Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer\u2019s disease","volume":"20","author":"Loskutova","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179925_ref113","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer\u2019s disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179925_ref114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/nimg.2001.0848","article-title":"In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer\u2019s disease","volume":"14","author":"Baron","year":"2001","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-179925_ref115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neurobiolaging.2003.08.011","article-title":"The influence of sex on limbic volume and perfusion in AD","volume":"25","author":"Callen","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179925_ref116","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/WNL.57.9.1669","article-title":"Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD","volume":"57","author":"Callen","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-179925_ref117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","article-title":"Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein","volume":"9","author":"Niwa","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179925_ref118","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jalz.2008.04.005","article-title":"Basal forebrain atrophy is a presymptomatic marker for Alzheimer\u2019s disease","volume":"4","author":"Hall","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179925_ref119","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated Abeta oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-179925_ref120","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.0872-14.2014","article-title":"Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons","volume":"34","author":"Ishii","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref121","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/nmt.14.33","article-title":"The sleep-wake cycle and Alzheimer\u2019s disease: What do we know?","volume":"4","author":"Lim","year":"2014","journal-title":"Neurodegener Dis Manag"},{"key":"10.3233\/JAD-179925_ref122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/089198879901200203","article-title":"Characteristics of sleep disturbance in community-dwelling Alzheimer\u2019s disease patients","volume":"12","author":"McCurry","year":"1999","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-179925_ref123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.sleep.2004.12.005","article-title":"Sleep disturbance in mild to moderate Alzheimer\u2019s disease","volume":"6","author":"Moran","year":"2005","journal-title":"Sleep Med"},{"key":"10.3233\/JAD-179925_ref124","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology\u2013a bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-179925_ref125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopsycho.2005.11.002","article-title":"The contribution of sleep to improvements in working memory scanning speed: A study of prolonged sleep restriction","volume":"72","author":"Casement","year":"2006","journal-title":"Biol Psychol"},{"key":"10.3233\/JAD-179925_ref126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1101\/lm.48803","article-title":"Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning","volume":"10","author":"Graves","year":"2003","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-179925_ref127","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nlm.2013.11.021","article-title":"Sleep deprivation during a specific 3-hour time window post-training impairs hippocampal synaptic plasticity and memory","volume":"109","author":"Prince","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-179925_ref128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.psych.56.091103.070307","article-title":"Sleep, memory, and plasticity","volume":"57","author":"Walker","year":"2006","journal-title":"Ann Rev Psychol"},{"key":"10.3233\/JAD-179925_ref129","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.1062856","article-title":"The role of sleep in learning and memory","volume":"294","author":"Maquet","year":"2001","journal-title":"Science"},{"key":"10.3233\/JAD-179925_ref130","doi-asserted-by":"crossref","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","article-title":"Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer\u2019s disease pathology","volume":"4","author":"Roh","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-179925_ref131","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.3233\/JAD-179925_ref132","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1084\/jem.20141788","article-title":"Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer\u2019s disease","volume":"211","author":"Roh","year":"2014","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-179925_ref133","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)61223-0","article-title":"Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer\u2019s disease with injury to pedunculopontine cholinergic neurons","volume":"167","author":"Zhang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179925_ref134","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuroscience.2004.11.018","article-title":"Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer\u2019s disease: A role for cholinergic transmission","volume":"131","author":"Wisor","year":"2005","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-179925_ref135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00690393","article-title":"Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon","volume":"64","author":"Rudelli","year":"1984","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179925_ref136","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-b oligomers in mice","volume":"64","author":"Kincheski","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-179925_ref137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-3223(03)00543-2","article-title":"Depression in Alzheimer\u2019s disease: Heterogeneity and related issues","volume":"54","author":"Lee","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179925_ref138","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/JGP.0b013e318165dbae","article-title":"Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria","volume":"16","author":"Teng","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref139","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gps.2508","article-title":"Diagnostic criteria for apathy in clinical practice","volume":"26","author":"Mulin","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-179925_ref140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/WAD.0b013e31820e7c45","article-title":"Depression in patients with moderate Alzheimer disease: A prospective observational cohort study","volume":"25","author":"Porta-Etessam","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-179925_ref141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer\u2019s disease: A cross-sectional study using diagnostic criteria","volume":"31","author":"Benoit","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179925_ref142","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.archger.2008.09.002","article-title":"Depression and apathy in dementia: Same syndrome or different constructs? A critical review","volume":"49","author":"Tagariello","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JAD-179925_ref143","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1073\/pnas.89.19.9117","article-title":"Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1","volume":"89","author":"Kent","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179925_ref144","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-179925_ref145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","article-title":"Depression as a microglial disease","volume":"38","author":"Yirmiya","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-179925_ref146","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2015.11.011","article-title":"Microglial dysfunction connects depression and Alzheimer\u2019s disease","volume":"55","author":"Santos","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-179925_ref147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/2051-5960-1-62","article-title":"The airbag problem-a potential culprit for bench-to-bedside translational efforts: Relevance for Alzheimer\u2019s disease","volume":"1","author":"Krstic","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179925_ref148","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-179925_ref149","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat Immunol"},{"key":"10.3233\/JAD-179925_ref150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.neubiorev.2012.02.011","article-title":"APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)","volume":"36","author":"Lalonde","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-179925_ref151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.3233\/JAD-179925_ref152","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-179925_ref153","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","article-title":"Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder","volume":"170","author":"Tuglu","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-179925_ref154","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: A shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-179925_ref155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-179925_ref156","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.lfs.2006.02.015","article-title":"Antidepressant-like effect of saponins extracted from Chaihu-jia-longgu-muli-tang and its possible mechanism","volume":"79","author":"Zhu","year":"2006","journal-title":"Life Sci"},{"key":"10.3233\/JAD-179925_ref157","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-179925_ref158","doi-asserted-by":"crossref","first-page":"277","DOI":"10.55782\/ane-2005-1563","article-title":"Serotoninergic impairment and aggressive behavior in Alzheimer\u2019s disease","volume":"65","author":"Zarros","year":"2005","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.3233\/JAD-179925_ref159","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0033-3182(97)71461-0","article-title":"A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer\u2019s disease","volume":"38","author":"Taragano","year":"1997","journal-title":"Psychosomatics"},{"key":"10.3233\/JAD-179925_ref160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S104161020100761X","article-title":"A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer\u2019s disease","volume":"13","author":"Petracca","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-179925_ref161","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.biopsych.2006.03.082","article-title":"Hippocampal neurogenesis: Regulation by stress and antidepressants","volume":"59","author":"Dranovsky","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179925_ref162","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.1523\/JNEUROSCI.2911-13.2013","article-title":"The importance of serotonin in exercise-induced adult neurogenesis: New evidence from Tph2-\/- mice","volume":"33","author":"Beckman","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref163","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1465-9921-8-35","article-title":"Anti-inflammatory properties of desipramine and fluoxetine","volume":"8","author":"Roumestan","year":"2007","journal-title":"Respir Res"},{"key":"10.3233\/JAD-179925_ref164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0034-1377041","article-title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients","volume":"47","author":"Mokhber","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.3233\/JAD-179925_ref165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/jcp.0b013e31814b98c1","article-title":"Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer\u2019s dementia? A double-blind, placebo-controlled clinical trial","volume":"27","author":"Mowla","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.3233\/JAD-179925_ref166","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","article-title":"Elevated circulating tumor necrosis factor levels in Alzheimer\u2019s disease","volume":"129","author":"Fillit","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-179925_ref167","first-page":"223","article-title":"Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer\u2019s disease patients","volume":"66","author":"Strauss","year":"1992","journal-title":"Lab Invest"},{"key":"10.3233\/JAD-179925_ref168","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol"},{"key":"10.3233\/JAD-179925_ref169","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"Suppl 1","key":"10.3233\/JAD-179925_ref170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jnc.13062","article-title":"Microglia and neuroprotection","volume":"136","author":"Chen","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179925_ref171","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1007\/s00018-014-1670-8","article-title":"Microglia and inflammation: Conspiracy, controversy or control?","volume":"71","author":"Fernandes","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-179925_ref172","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-179925_ref173","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-179925_ref174","first-page":"1005","article-title":"Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179925_ref175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","article-title":"Microglial and macrophage polarization-new prospects for brain repair","volume":"11","author":"Hu","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-179925_ref176","first-page":"792","article-title":"An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory","volume":"140","author":"Fan","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-179925_ref177","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2990.1996.tb01112.x","article-title":"Apolipoprotein E distribution among different plaque types in Alzheimer\u2019s disease: Implications for its role in plaque progression","volume":"22","author":"Sheng","year":"1996","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-179925_ref178","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1523\/JNEUROSCI.3024-08.2008","article-title":"Inflammatory response in the hippocampus of PS1M146L\/APP751SL mouse model of Alzheimer\u2019s disease: Age-dependent switch in the microglial phenotype from alternative to classic","volume":"28","author":"Jimenez","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179925_ref179","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-179925_ref180","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-179925_ref181","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1567205014666170829100100","article-title":"Modulation of inflammation as a way of delaying Alzheimer\u2019s disease progression: The diet\u2019s role","volume":"15","author":"Businaro","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-179925_ref182","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-179925_ref183","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-179925_ref184","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer\u2019s disease","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JAD-179925_ref185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in Alzheimer\u2019s disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-179925_ref186","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMcibr1503954","article-title":"TREM2 and risk of Alzheimer\u2019s disease - friend or foe?","volume":"372","author":"Tanzi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-179925_ref187","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-179925_ref188","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.3233\/JAD-179925_ref189","doi-asserted-by":"crossref","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-179925_ref190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: An unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-179925_ref191","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.3233\/JAD-179925_ref192","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice.eaaf","volume":"9","author":"Shi","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-179925_ref193","first-page":"137","article-title":"Toll-like receptors in Alzheimer\u2019s disease","volume":"336","author":"Landreth","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.3233\/JAD-179925_ref194","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer\u2019s disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.3233\/JAD-179925_ref195","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.brainresrev.2008.09.001","article-title":"Toll-like receptors in neurodegeneration","volume":"59","author":"Okun","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.3233\/JAD-179925_ref196","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1091\/mbc.e17-06-0416","article-title":"Neuroprotective astrocyte-derived insulin\/IGF-1 stimulate endocytic processing and extracellular release of neuron-bound Ab oligomers","volume":"28","author":"Pitt","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.3233\/JAD-179925_ref197","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-179925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:38Z","timestamp":1777370858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-179925"}},"subtitle":[],"editor":[{"given":"G.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"J.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"P.I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"A.A.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"M.","family":"Tabaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":195,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-179925","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}